XCELL THERAPEUTICS INC. financial statements, including revenue, expenses, and profit

The total revenue of 373110 for the last quarter is 476.51 M KRW, and it's 4.09% higher compared to the previous quarter. The net income of Q4 24 is -2.44 B KRW.